Besins Healthcare to launch production of progesterone in Russia

Bangkok, Thailand-based Besins Healthcare will launch the production of its Utrozhestan (progesterone) drug in Russia at the facilities of its local plant in the Yaroslavl region by September of the current year, according to recent statements of some Yarosolavl media reports and sources close to the company.

The drug is expected to be one of the most important in the Besins’ Russian portfolio included in the list of vital and essential drugs in Russia, which means that its procurement will be conducted by the Russian government via state tenders.

So far, the value of investments in the project amounted to 700 million roubles ($12 million). The production capacity will reach 10 million packages per year, that will allow to completely meet the entire needs of Russia in this drug.